Form 4: USCB Executive Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


USCB Financial Holdings' EVP and Chief Risk Officer, Maricarmen Logrono, disposed of 581 shares of Class A Voting Common Stock to cover tax liabilities.

Summary

  • Maricarmen Logrono, EVP and Chief Risk Officer of USCB Financial Holdings, Inc., reported a transaction.
  • On January 21, 2026, Logrono disposed of 581 shares of Class A Voting Common Stock.
  • The disposition was for tax liability, at a price of $20.38 per share.
  • Following this transaction, Logrono beneficially owns 10,132 shares of Class A Voting Common Stock directly.
  • These 10,132 shares include restricted stock grants with varying vesting schedules: 876 shares (vesting from Jan 22, 2025), 808 shares (vesting from March 8, 2024), and 3,920 shares (vesting from Jan 21, 2026).
  • Logrono also holds 15,000 options to purchase Class A Voting Stock with an exercise price of $12.05, granted on September 27, 2021, and expiring on September 27, 2031.
  • These options vest at a rate of one-third per year commencing on September 27, 2022.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-planned disposition of shares by an executive to cover tax obligations, which is a common practice for equity compensation. It does not indicate a change in the executive's confidence in the company, especially given the continued significant holdings and options.

Positives

  • The transaction was a disposition for tax liability (Code F), which is a common and routine practice for executives receiving equity compensation, rather than a discretionary sale.
  • The executive continues to hold a significant number of shares (10,132) and options (15,000), indicating continued alignment with shareholder interests.
  • The transaction was made under a Rule 10b5-1(c) plan, suggesting a pre-planned and orderly disposition.

Future Outlook

N/A

Industry Context

N/A

Stakeholder Impact

  • Shareholders: Minimal direct impact as it's a routine tax-related sale, not a discretionary sale. The executive maintains significant holdings.
  • Employees: No direct impact.
  • Customers: No direct impact.
  • Suppliers: No direct impact.
  • Creditors: No direct impact.

Next Steps

  • Continued vesting of restricted stock grants on January 22, 2025, March 8, 2024, and January 21, 2026.
  • Continued vesting of stock options on September 27, 2022, and subsequent anniversaries of the grant date (September 27, 2021).
  • Expiration of stock options on September 27, 2031.

Key Dates

DateDescription
09/27/2021Grant date for 15,000 options to purchase Class A Voting Stock.
09/27/2022Commencement of vesting for options (one-third per year) and date exercisable.
03/08/2024Commencement of vesting for 808 shares of restricted stock (from a 2,426 share grant).
01/22/2025Commencement of vesting for 876 shares of restricted stock (from a 2,630 share grant).
01/21/2026Date of disposition of 581 shares of Class A Voting Common Stock for tax liability and commencement of vesting for 3,920 shares of restricted stock (from a 5,880 share grant).
01/23/2026Signature date of the reporting person.
09/27/2031Expiration date for options to purchase Class A Voting Stock.

Recommendation

hold

This Form 4 details a routine, pre-planned disposition of shares by a key executive to cover tax liabilities associated with equity compensation. It is not a discretionary sale and was executed under a Rule 10b5-1 plan, which typically signals a non-event for investment decisions. The executive retains substantial equity and options, indicating continued alignment with shareholder interests. Therefore, this filing alone does not warrant a change in investment recommendation; a "hold" stance is appropriate, pending further fundamental analysis of the company's performance and outlook.

Keywords

USCB Financial Holdings, USCB, Form 4, Insider Trading, Stock Sale, Executive Compensation, Restricted Stock, Stock Options, Maricarmen Logrono, Chief Risk Officer, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.